|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01419 HUMAN HEALTH
Nominal 
0.820 0.000 (0.000%) | 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 342,351 | 8.412% | 644,431 | 590,819 | 1,001,746 | 1,121,793 |
| Cost of Sales | (182,881) | 9.464% | (348,974) | (320,968) | (408,510) | (462,108) |
| Gross Profit | 159,470 | 7.230% | 295,457 | 269,851 | 593,236 | 659,685 |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 253 | -- | (238) | (1,271) | (1,543) | (1,977) | |
| Profit / (Loss) before Taxation | 22,654 | 12.897% | 29,942 | 26,564 | 238,816 | 445,262 | |
| Taxation | (3,756) | 15.783% | (3,310) | (2,375) | (57,977) | (69,953) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (646) | -- | (296) | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 18,252 | 8.501% | 26,336 | 24,189 | 180,839 | 375,309 | |
| 2025/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | (177) | -96.277% | (6,152) | (8,932) | (194) | 2,735 |
| Depreciation & Amortisation | 33,087 | 0.786% | 67,706 | 68,009 | 74,790 | 63,074 |
| Directors' Emoluments | -- | -- | 14,587 | 13,214 | 19,253 | 13,049 |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 4.800 | 9.091% | 6.900 | 6.400 | 47.600 | 98.900 |
| DPS (cts) | 0.000 | -- | 3.000 | 2.800 | 16.000 | 30.000 |
| Dividend Payout Ratio (%) | -- | -- | 43.478% | 43.750% | 33.613% | 30.334% |
| Cash flow per share ($) | -- | -- | 0.260 | 0.035 | 1.750 | 0.779 |
| NBV per share ($) | 2.072 | -- | 2.060 | 2.020 | 2.129 | 1.955 |
| Remarks: | Real time quote last updated: 04/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 18,252 |
| %Change | 8.501% |
| EPS / (LPS) | HKD 0.048 |
| NBV Per Share ($) | HKD 2.072 |